MedTrace Logo

AMES Treatment of the Impaired Leg in Chronic Stroke Patients

NCT01378637 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-12-08

No results posted yet for this study

Summary

The purpose of this protocol is to determine if individuals who had a stroke more than one year before entering the study and whose ankles remain substantially impaired are able to sense and move the affected leg better after 9-13 weeks of treatment with a robotic therapy device (AMES).

Conditions

  • Stroke
  • Cerebrovascular Accident
  • Hemiparesis

Interventions

DEVICE

AMES- Leg treatment

30 minutes of treatment of the leg consisting of the AMES device passively moving the ankle between plantarflexion and dorsiflexion with vibration of the tendons being stretched, while the participant tries to assist in the movement as much as possible.

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • Northwestern University

    collaborator OTHER

  • Shirley Ryan AbilityLab

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • AMES Technology

    lead INDUSTRY

Principal Investigators

  • Barry Oken, MD · Oregon Health and Science University

  • Elliot Roth, MD · Northwestern University/Rehabilitation Institute of Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-12-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01378637 on ClinicalTrials.gov